38. Kantoff PW, Gillio AP, McLachlin JR et al. Expression of human adenosine 
deaminase in nonhuman primates after retrovirus-mediated gene transfer. J Exp 
Med 166:219-34; 1987. 
39. Oval J, Hershberg R, Gansbacher B et al. Expression of functional epidermal 
growth factor receptors in human hematopoietic cell lines. Cancer Res 51:150-6; 
1991. 
40. Hoon D, Hayashi Y. Specific cytotoxic T cells (CTL’s) to human uveal melanoma. 
Proc Amer Assoc Cancer Res 32:236; 1991. 
41. Hayashi Y, Hoon D. Cytotoxic T cell (CTL) restricted recognition of common 
antigens on HLA-A2 matched allogenic human melanoma. Proc Amer Assoc 
Cancer Res 32:238; 1991. 
42. Livingston PO, Kaelin K, Pinsky C et al. Serologic response of patients with Stage 
II melanoma to allogenic melanoma cell vaccines. Cancer 56:2194-2200; 1985. 
43. Livingston PO, Takeyama H, Pollack MS et al. Serologic response of melanoma 
patients to vaccines derived from allogenic cultured melanoma cells. Int J Cancer 
31:567-75; 1983. 
44. Livingston PO, Watanabe T, Shiku et al. Serologic response of melanoma patients 
receiving melanoma vaccines. Autologous cultured melanoma cells. Int J Cancer 
30:413-22; 1982. 
45. Markowitz D, Goff S, Bank A et al. A safe packaging line for gene transfer: 
separating viral genes on two different plasmids. J Virology 62: 1120; 1988. 
46. Crowley NJ, Slinghuff CL, Darrow TL et al. Generation of human autologous 
tumor specific cytotoxic T cells using HLA-A2 matched allogenic melanoma. 
Cancer Research 50:492; 1990. 
47. Crowley NJ, Darrow TL, Quinn- Allen MA et al. MHC-restricted recognition of 
autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction 
by a dominant HLA-A allele. J Immunol 146: 1692-9; 1991. 
48. Pandolfini F, Boyle LA, Trentin L et al. Expression of HLA-A2 antigen in human 
melanoma cell lines and its role in T-cell recognition. Cancer Resear 51:3164- 
70; 1991. 
49. Reily EB, Antognetti G. Increased tumor- specific CTL activity in human tumor- 
infiltrating lymphocytes stimulated with autologous tumor lines. Cell Immunol 
135:526-33; 1991. 
Recombinant DNA Research, Volume 15 
[935] 
